Pfizer has entered an exclusive global licensing agreement with YaoPharma for YP05002, an oral GLP-1 receptor agonist in Phase 1 for chronic weight management. The deal includes a USD 150 million upfront payment and potential milestone payments of up to USD 1.935 billion.
JD secures 59.8% stake in German electronics retailer Ceconomy, with total control reaching 85.2% alongside partner Convergenta. The deal, pending regulatory approval, marks JD's strategic move into overseas markets.
5 days ago • China
WACKER and its joint-venture partner SICO Performance Material have inaugurated a 2,300-square-meter application development center in Jining, China, focused on organofunctional silanes. The facility is designed to accelerate additive innovation and commercialization for plastics, coatings and adhesives industries across high-growth Asian markets.
5 days ago • ChinaThe African Development Bank Group has approved a EUR 6.5 million commitment to the Saviu II venture capital fund to strengthen seed-stage technology financing in Francophone West and Central Africa. The investment, supported by the European Commission under Boost Africa, aims to accelerate digital entrepreneurship and regional market integration.
STRABAG’s subsidiary ZÜBLIN has secured two large-scale contracts from Codelco to advance the underground transformation of the Chuquicamata copper mine in Chile. The project includes more than 54 kilometres of tunnelling and critical infrastructure works, with completion targeted for 2031 and a workforce of around 1,200.
Mizoram has proposed a ₹174.7 billion budget for FY2026–27, with allocations focused on agriculture, connectivity and social infrastructure. The plan includes continued funding for farmer support programmes and supplementary grants of ₹37.24 billion for the current fiscal, reflecting a calibrated approach to fiscal management and development spending.
Blue Jet Healthcare will invest approximately ₹23 billion to establish a greenfield pharmaceutical manufacturing complex in Andhra Pradesh’s Rambilli Industrial Park. The phased project, expected to be operational by FY2028–29, will expand capacity for contrast media intermediates and specialty chemicals while creating 2,000 jobs.